Penn receives $12 million NIH grant to research personalized approach to smoking cessation

September 7, 2010

Penn Medicine News Release

PHILADELPHIA  A variety of smoking cessation treatments are
currently available for the more than 18 million adult Americans try to
quit smoking each year, but success rates vary widely. Despite the
importance of quitting smoking, more personalized approaches to smoking
cessation treatment are needed to help smokers pick the right method
that will work best for them. A major new personalized medicine clinical
trial, led by addiction researchers at the University of Pennsylvania,
will study how a smokers' genetic make-up influences their quitting
success.

A team of researchers led by Caryn Lerman, PhD, professor of
Psychiatry at the University of Pennsylvania School of Medicine and
Annenberg Public Policy Center, has received a $12 million five-year
grant to study the pharmacogenetics of nicotine addiction treatment... Read More